HealthCSPC Pharmaceutical’s SYH2059 KAT6 Inhibitor Receives FDA Clinical Trial ApprovalCSPC Pharmaceutical’s SYH2059 KAT6 inhibitor receives FDA approval for clinical trials in the U.S., marking a significan…David Hale·April 25, 2026, 3:08 AM
